• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure.

作者信息

Nassif Michael E, Spertus John A, Tang Fengming, Windsor Sheryl L, Jones Philip, Thomas Merrill, Khariton Yevgeniy, Brush John, Gordon Robert A, Jermyn Rita, Jonsson Orvar, Lamba Sumant, Shavelle David M, Kosiborod Mikhail N

机构信息

Saint Luke's Mid America Heart Institute, Kansas City, MO (M.E.N., J.A.S., F.T., S.L.W., P.J., M.T., Y.K., M.N.K.).

University of Missouri-Kansas City (M.E.N., J.A.S., M.T., Y.K., M.N.K.).

出版信息

Circ Heart Fail. 2021 Nov;14(11):e008446. doi: 10.1161/CIRCHEARTFAILURE.121.008446. Epub 2021 Oct 26.

DOI:10.1161/CIRCHEARTFAILURE.121.008446
PMID:34696602
Abstract
摘要

相似文献

1
Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure.动态血流动力学压力变化与心力衰竭症状之间的关联
Circ Heart Fail. 2021 Nov;14(11):e008446. doi: 10.1161/CIRCHEARTFAILURE.121.008446. Epub 2021 Oct 26.
2
Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.在慢性心力衰竭患者中联合使用肼屈嗪预防对硝酸盐血流动力学效应的耐受性。
J Am Coll Cardiol. 1995 Dec;26(7):1575-80. doi: 10.1016/0735-1097(95)00368-1.
3
Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.静脉注射硝酸甘油对充血性心力衰竭血流动力学的影响。
Angiology. 1982 May;33(5):294-301. doi: 10.1177/000331978203300502.
4
Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
Eur Heart J. 1980 Jun;1(3):157-63. doi: 10.1093/oxfordjournals.eurheartj.a061114.
5
Dobutamine-induced changes in pulmonary artery pressure in patients with congestive heart failure and their relation to abnormalities of lung diffusing capacity.
Am J Cardiol. 1998 Nov 15;82(10):1296-8, A10. doi: 10.1016/s0002-9149(98)00622-5.
6
Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.大剂量经皮硝酸甘油对慢性充血性心力衰竭患者的血流动力学及激素影响
Am J Cardiol. 1985 Sep 15;56(8):555-9. doi: 10.1016/0002-9149(85)91184-1.
7
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.左西孟旦对重度心力衰竭患者的急性血流动力学及临床效应。研究人员
Circulation. 2000 Oct 31;102(18):2222-7. doi: 10.1161/01.cir.102.18.2222.
8
Late Migration of a CardioMEMS Wireless Pulmonary Artery Hemodynamic Monitoring Sensor.CardioMEMS无线肺动脉血流动力学监测传感器的晚期移位
Circ Heart Fail. 2017 Apr;10(4). doi: 10.1161/CIRCHEARTFAILURE.117.003948.
9
[Hemodynamic characteristics of heart transplant patients in the early postoperative period].
Z Kardiol. 1991 Nov;80(11):681-6.
10
Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure.
Clin Physiol. 1988 Feb;8(1):57-64. doi: 10.1111/j.1475-097x.1988.tb00262.x.

引用本文的文献

1
Physiologic Phenotyping of Responses to Exercise and Activity in Heart Failure.心力衰竭患者对运动和活动反应的生理表型分析
Circ Res. 2025 Jul 7;137(2):290-315. doi: 10.1161/CIRCRESAHA.125.325534. Epub 2025 Jul 3.
2
Knowledge domain and emerging trends in empagliflozin for heart failure: A bibliometric and visualized analysis.恩格列净治疗心力衰竭的知识领域与新趋势：文献计量学与可视化分析
Front Cardiovasc Med. 2022 Nov 3;9:1039348. doi: 10.3389/fcvm.2022.1039348. eCollection 2022.
3
Empagliflozin for Patients with Heart Failure and Type 2 Diabetes Mellitus: Clinical Evidence in Comparison with Other Sodium-Glucose Co-transporter-2 Inhibitors and Potential Mechanism.
恩格列净用于心力衰竭合并2型糖尿病患者：与其他钠-葡萄糖协同转运蛋白2抑制剂比较的临床证据及潜在机制
J Cardiovasc Transl Res. 2023 Apr;16(2):327-340. doi: 10.1007/s12265-022-10302-4. Epub 2022 Aug 15.
4
The development and initial validation of the PROMIS®+HF-27 and PROMIS+HF-10 profiles.PROMIS®+HF-27 和 PROMIS+HF-10 量表的开发和初步验证。
ESC Heart Fail. 2022 Oct;9(5):3380-3392. doi: 10.1002/ehf2.14061. Epub 2022 Jul 15.
5
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond.老年心力衰竭患者2型糖尿病的药物治疗：随机试验及其他研究
Heart Fail Rev. 2023 May;28(3):667-681. doi: 10.1007/s10741-021-10182-x. Epub 2021 Dec 2.